COVID-19 Booster Vaccination Among Individuals With Schizophrenia in Israel.

Tzur Bitan, Dana; Kridin, Khalaf; Givon-Lavi, Noga; Krieger, Israel; Kaliner, Ehud; Cohen, Arnon Dov; Weinstein, Orly

Tzur Bitan, Dana; Kridin, Khalaf; Givon-Lavi, Noga; Krieger, Israel; Kaliner, Ehud; Cohen, Arnon Dov; Weinstein, Orly.

Afiliação

Tzur Bitan D; Department of Behavioral Sciences, Ariel University, Ariel, Israel.
Kridin K; Shalvata Mental Health Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Givon-Lavi N; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Krieger I; Unit of Dermatology and Skin Research Laboratory, Baruch Padeh Poria Medical Center, Tiberias, Israel.
Kaliner E; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
Cohen AD; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Weinstein O; The Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer Sheva, Israel.

JAMA Psychiatry ; 79(5): 508-512, 2022 05 01.

Article em En | MEDLINE | ID: mdl-35353114

Assuntos

COVID-19; Esquizofrenia; Adulto; COVID-19/prevenção & controle; Vacinas contra COVID-19/uso terapêutico; Estudos de Coortes; Feminino; Humanos; Israel/epidemiologia; Masculino; Pessoa de Meia-Idade; Estudos Retrospectivos; Vacinação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: JAMA Psychiatry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google